GSK’s buyout of IDRx and Eli Lilly’s deal for Scorpion Therapeutics — both announced Monday — fit what’s been a trend the past year: privately held companies opting for a deal over an initial public ...
Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...
What difference will having a FREE account make? Setting up a Free account with OnTableTop unlocks a load of additional features and content (see below). You can then get involved with our Tabletop ...